NPI: 1396731105 · LAREDO, TX 78045 · Ambulatory Surgical Clinic/Center · NPI assigned 09/27/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 09/27/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 1,137 | $42K |
| 2020 | 22,669 | $1.89M |
| 2021 | 153,484 | $8.24M |
| 2022 | 227,177 | $12.29M |
| 2023 | 258,540 | $18.57M |
| 2024 | 144,470 | $11.28M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 50,199 | 47,969 | $25.65M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 16,679 | 15,769 | $11.27M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 37,986 | 36,892 | $2.47M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 29,142 | 28,270 | $1.45M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,596 | 3,430 | $1.37M |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 55,691 | 34,995 | $1.31M |
| 87430 | 32,264 | 31,292 | $776K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 27,494 | 26,456 | $575K |
| 71046 | Radiologic examination, chest; 2 views | 9,261 | 8,981 | $451K |
| 87420 | 19,521 | 18,995 | $416K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 48,670 | 45,083 | $391K |
| 80053 | Comprehensive metabolic panel | 37,388 | 34,723 | $383K |
| 71045 | Radiologic examination, chest; single view | 11,772 | 11,272 | $373K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 5,358 | 4,959 | $354K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 8,261 | 7,680 | $340K |
| 87070 | 27,955 | 27,102 | $340K | |
| 70450 | Computed tomography, head or brain; without contrast material | 2,644 | 2,531 | $312K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3,984 | 3,703 | $270K |
| 59025 | Fetal non-stress test | 2,041 | 1,704 | $233K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,123 | 1,071 | $179K |
| 80061 | Lipid panel | 12,301 | 12,142 | $167K |
| 84443 | Thyroid stimulating hormone (TSH) | 10,643 | 10,459 | $166K |
| 81001 | 45,897 | 43,317 | $166K | |
| 74018 | 3,328 | 3,233 | $148K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1,917 | 1,861 | $123K |
| 76801 | 1,051 | 943 | $121K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 11,659 | 11,323 | $120K |
| 83525 | 7,395 | 7,285 | $116K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4,853 | 4,804 | $103K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 3,599 | 2,562 | $93K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 11,674 | 11,048 | $92K |
| 81025 | 7,858 | 7,475 | $83K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 9,215 | 9,062 | $79K |
| 83690 | 10,498 | 9,906 | $74K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,168 | 5,620 | $74K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3,639 | 3,382 | $68K |
| 80050 | General health panel | 804 | 779 | $59K |
| 96361 | Intravenous infusion, hydration; each additional hour | 940 | 870 | $52K |
| 82977 | 5,202 | 5,125 | $52K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1,010 | 990 | $49K |
| G0378 | Hospital observation service, per hour | 119 | 104 | $48K |
| 84436 | 5,081 | 4,985 | $45K | |
| 80076 | 4,345 | 4,261 | $44K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 674 | 614 | $36K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 142 | 141 | $36K |
| 72125 | Computed tomography, cervical spine; without contrast material | 555 | 531 | $34K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1,562 | 1,279 | $33K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,266 | 723 | $33K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 9,213 | 8,434 | $31K |
| 87186 | 4,772 | 4,294 | $30K | |
| 74019 | 519 | 506 | $30K | |
| 73610 | 565 | 542 | $28K | |
| 86703 | 1,707 | 1,629 | $27K | |
| 84484 | 5,239 | 3,530 | $27K | |
| 83880 | 2,126 | 2,023 | $26K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 768 | 766 | $25K |
| 84481 | 1,088 | 1,079 | $25K | |
| 72082 | 214 | 212 | $24K | |
| 84702 | 1,646 | 1,430 | $24K | |
| S0164 | Injection, pantoprazole sodium, 40 mg | 338 | 300 | $23K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 906 | 197 | $23K |
| 84460 | 3,043 | 3,000 | $22K | |
| 86850 | 897 | 805 | $22K | |
| 84450 | 3,042 | 2,999 | $22K | |
| 86003 | 624 | 257 | $20K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 575 | 531 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 578 | 533 | $20K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 379 | 362 | $19K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 767 | 765 | $19K |
| 83655 | 1,122 | 1,114 | $19K | |
| 87077 | 3,159 | 2,761 | $18K | |
| 73630 | 503 | 488 | $18K | |
| 84439 | 2,811 | 2,754 | $18K | |
| 74022 | 208 | 202 | $18K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 84 | 69 | $17K |
| 83605 | 2,267 | 2,000 | $17K | |
| 85027 | 4,160 | 3,917 | $17K | |
| 81002 | 4,467 | 2,542 | $16K | |
| 85610 | 5,445 | 5,069 | $15K | |
| 82550 | 2,970 | 2,805 | $15K | |
| 70260 | 190 | 187 | $14K | |
| 73130 | 313 | 302 | $14K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 109 | 106 | $12K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 210 | 201 | $12K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,490 | 2,284 | $11K |
| 71250 | 152 | 150 | $11K | |
| 87040 | 1,882 | 1,148 | $11K | |
| 73564 | 291 | 277 | $11K | |
| 0353U | 284 | 267 | $10K | |
| 72100 | 259 | 257 | $9K | |
| 85730 | 3,114 | 2,906 | $9K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 301 | 73 | $9K |
| 87209 | 378 | 357 | $9K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 6,302 | 6,091 | $9K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 156 | 152 | $7K |
| 73030 | 325 | 305 | $7K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 175 | 162 | $7K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 1,821 | 1,540 | $7K |
| 83735 | 2,210 | 1,938 | $6K | |
| 82248 | 1,186 | 900 | $6K | |
| 87899 | 476 | 278 | $6K | |
| 84703 | 765 | 724 | $6K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 43 | 41 | $5K |
| 97163 | 76 | 72 | $5K | |
| 87425 | 320 | 308 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 14 | 12 | $5K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 115 | 110 | $5K |
| 82247 | 846 | 670 | $5K | |
| 36415 | Collection of venous blood by venipuncture | 69,854 | 62,359 | $5K |
| 82150 | 799 | 775 | $5K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 193 | 188 | $5K |
| 82728 | 1,025 | 1,012 | $5K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 145 | 129 | $5K |
| 87177 | 378 | 357 | $5K | |
| 87045 | 360 | 345 | $5K | |
| 83630 | 156 | 152 | $4K | |
| 86592 | 1,036 | 964 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 78 | 76 | $4K |
| 87581 | 142 | 141 | $4K | |
| 87486 | 142 | 141 | $4K | |
| 86901 | 1,730 | 1,572 | $4K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 61 | 59 | $4K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 781 | 658 | $4K |
| 82607 | 1,311 | 1,298 | $4K | |
| 90715 | 128 | 126 | $4K | |
| 86900 | 1,559 | 1,422 | $4K | |
| 70360 | 60 | 58 | $4K | |
| 87260 | 170 | 165 | $3K | |
| 73110 | 68 | 63 | $3K | |
| 87279 | 129 | 122 | $3K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1,810 | 1,663 | $3K |
| 83550 | 806 | 796 | $3K | |
| 70486 | 16 | 16 | $2K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 105 | 53 | $2K |
| 83540 | 1,027 | 1,014 | $2K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,356 | 1,232 | $2K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 487 | 428 | $2K |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 56 | 40 | $2K |
| 85379 | 291 | 280 | $2K | |
| 82270 | 632 | 601 | $2K | |
| 86677 | 151 | 95 | $2K | |
| 86140 | 506 | 484 | $2K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 422 | 368 | $2K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 12 | 12 | $2K |
| 87340 | 154 | 147 | $1K | |
| 83970 | 175 | 175 | $1K | |
| C9113 | Injection, pantoprazole sodium, per vial | 113 | 100 | $1K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1,870 | 1,641 | $1K |
| 76770 | 12 | 12 | $1K | |
| 85245 | 39 | 37 | $1K | |
| 85246 | 39 | 37 | $1K | |
| 85247 | 39 | 37 | $1K | |
| 82553 | 273 | 258 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 13 | 12 | $1K |
| 82570 | 1,076 | 995 | $1K | |
| 86762 | 81 | 77 | $1K | |
| 80069 | 906 | 829 | $1K | |
| 85652 | 791 | 756 | $1K | |
| 82043 | 993 | 985 | $977.91 | |
| 72131 | 12 | 12 | $886.10 | |
| 82951 | 67 | 58 | $882.83 | |
| 87338 | 37 | 34 | $750.43 | |
| 73090 | 15 | 13 | $717.77 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 133 | 119 | $704.52 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1,274 | 1,010 | $699.01 |
| 83986 | 134 | 131 | $686.74 | |
| 72040 | 12 | 12 | $625.66 | |
| 82947 | 111 | 111 | $594.45 | |
| 73502 | 27 | 27 | $550.24 | |
| 87653 | 17 | 15 | $543.30 | |
| 84145 | 43 | 41 | $481.38 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 1,400 | 1,298 | $453.32 |
| 82542 | 13 | 13 | $365.65 | |
| 82746 | 134 | 134 | $355.63 | |
| 84156 | 351 | 343 | $349.75 | |
| 73700 | 13 | 12 | $339.93 | |
| 73562 | 13 | 13 | $329.56 | |
| 80074 | 13 | 13 | $327.69 | |
| 87210 | 57 | 54 | $321.57 | |
| 82378 | 28 | 24 | $307.03 | |
| 82785 | 12 | 12 | $289.93 | |
| 73080 | 12 | 12 | $270.56 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,737 | 4,509 | $270.25 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 28 | 24 | $262.43 |
| 87324 | 19 | 18 | $228.44 | |
| 77080 | 51 | 51 | $209.43 | |
| 84550 | 147 | 144 | $134.35 | |
| 82272 | 32 | 29 | $122.37 | |
| 86803 | 14 | 14 | $108.47 | |
| 84479 | 25 | 25 | $107.63 | |
| 84153 | 84 | 83 | $87.22 | |
| 82565 | 36 | 36 | $60.36 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 47 | 41 | $50.90 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 82 | 77 | $48.62 |
| 85018 | 13 | 13 | $43.31 | |
| 84100 | 28 | 24 | $41.30 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 118 | 110 | $35.20 |
| J7510 | Prednisolone oral, per 5 mg | 181 | 171 | $23.35 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 87 | 79 | $20.12 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 47 | 38 | $19.38 |
| 84520 | 12 | 12 | $11.25 | |
| 87081 | 85 | 70 | $9.70 | |
| 82962 | 2,952 | 1,772 | $6.60 | |
| J2704 | Injection, propofol, 10 mg | 854 | 782 | $2.88 |
| A9270 | Non-covered item or service | 3,733 | 2,354 | $0.00 |
| 88342 | 29 | 25 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 13 | 13 | $0.00 |
| L3650 | Shoulder orthosis, figure of eight design abduction restrainer, prefabricated, off-the-shelf | 41 | 40 | $0.00 |
| 88313 | 14 | 13 | $0.00 | |
| 99152 | 15 | 12 | $0.00 | |
| C1780 | Lens, intraocular (new technology) | 40 | 37 | $0.00 |